| Bioactivity | 7-Methylguanosine 5'-diphosphate (7-Methyl-GDP) sodium, a cap analog, can be used in the synthesis of mRNA cap analogues[1]. |
| Invitro | 7-Methylguanosine 5'-diphosphate sodium inhibits binding of eukaryotic initiation factors to reovirus capped mRNA and complex formation involving uncapped mRNA or 18 S rRNA[1].T. brucei mRNA decapping enzyme (TbDcp2) that cleaves 7-Methylguanosine 5'-diphosphate sodium from capped RNA to generate pRNA, a substrate for TbCe1[2]. |
| Name | 7-Methylguanosine 5'-diphosphate sodium |
| CAS | 104809-16-7 |
| Formula | C11H16N5NaO11P2 |
| Molar Mass | 479.21 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
7-Methylguanosine 5'-diphosphate sodium
CAS: 104809-16-7 F: C11H16N5NaO11P2 W: 479.21
7-Methylguanosine 5'-diphosphate (7-Methyl-GDP) sodium, a cap analog, can be used in the synthesis of mRNA cap analogues
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.